Lynx1 Capital Management LP's Net Worth
$0
Estimate Recalculated Sep 18, 2024 05:40PM EST
Who is Lynx1 Capital Management LP?
Lynx1 Capital Management LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include TScan Therapeutics, Inc., and Passage BIO, Inc..
SEC CIK
Lynx1 Capital Management LP's CIK is 0001910456
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TScan Therapeutics, Inc. (TCRX) Snapshot price: $5.55
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 19
| |||
Form 4
| -0.24% | -25.40K |
$2.51 | -$63,952.50 | 10.46M |
May 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Passage BIO, Inc. (PASG) Snapshot price: $0.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |